Publication
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial
Journal Paper/Review - Apr 4, 2016
Schwentner Lukas, Janni Wolfgang, Kiechle Marion, Härtl Kristin, Weissenbacher Tobias, Friedl Thomas W P, Huober Jens, Scholz Christoph, Wischnik Arthur, Forstbauer Helmut, Rack Brigitte, Eichler Martin, Singer Susanne, Harbeck Nadia, Fink Visnja
Schwentner, Lukas
6
0
Harbeck, Nadia
38
0
Singer, Susanne
5
0
Eichler, Martin
5
0
Rack, Brigitte
16
0
Forstbauer, Helmut
7
0
Wischnik, Arthur
2
0
Scholz, Christoph
29
0
Huober, Jens
chief physicianBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
298
12
Friedl, Thomas W P
13
0
Weissenbacher, Tobias
4
0
Härtl, Kristin
1
0
Kiechle, Marion
4
0
Janni, Wolfgang
66
0
Fink, Visnja
8
0